o-Toluidine (2-Methylaniline)

o-Toluidine was synthesized in the 19th century along with other toluenediamine isomers as part of the systematic exploration of benzene-ring chemistry that produced the first synthetic dyes [1]. It has been used as a dye intermediate (producing various azo dyes), as a rubber antioxidant intermediate, as a chemical intermediate in the synthesis of other aromatic amines, and in the production of certain pharmaceutical and agricultural chemicals [2]. The Goodyear Tire and Rubber Company's Niagara Falls, NY plant (and its predecessor facilities) used o-toluidine in the manufacture of an antioxidant for rubber used in tires — workers at this facility who were exposed to o-toluidine developed bladder cancer at dramatically elevated rates [1]. An investigation by the WNY Occupational Health and Safety Center documented 50+ cases of bladder cancer among former workers over several decades, ultimately leading to IARC Group 1 reclassification [2].

Occupational inhalation and skin absorption during dye synthesis, rubber antioxidant production, and chemical manufacturing are the primary exposure routes [1]. Because o-toluidine is readily absorbed through skin, dermal contact during industrial handling is highly relevant [2]. General population exposure is very low — trace environmental presence near industrial facilities [1].

o-Toluidine undergoes N-hydroxylation by CYP1A2 and N-acetylation/deacetylation cycling to form reactive N-hydroxy intermediates that form DNA adducts at guanine in the urothelium [1]. The bladder is the primary target organ because the kidney concentrates these metabolites, exposing the bladder wall to reactive species during urine storage [2]. IARC reclassified o-toluidine to Group 1 (carcinogenic to humans) in 2012 based on sufficient evidence from the Goodyear worker cohort [1]. It is also a potent methemoglobin-former at higher doses [2].

Workers in rubber antioxidant production, dye synthesis, and chemical manufacturing using o-toluidine are the primary at-risk population [1]. The Goodyear Niagara Falls plant workers represent a cohort with documented 20-fold elevated bladder cancer incidence [2].

1. Occupational workers must wear impermeable gloves, as o-toluidine skin absorption is highly efficient [1]. 2. Local exhaust ventilation for all handling operations [2]. 3. Biological monitoring (urine o-toluidine and acetyl-o-toluidine) and bladder surveillance (urine cytology) for current and former workers [1]. 4. Workers with past occupational exposure should inform their physicians for bladder cancer surveillance [2].